CONNAUGHTON BERNADETTE sold 4.3% of their position (2K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $150.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/1/2025ACC: 0001662521-25-000005
Director
Since Sep 2018
-2K
Net shares
Net seller
$150.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.50K
Price / share
$75.09
Trade value
$112.63K
% of position
3.2%
10/1/2025
46.95K→45.45K
Common Stock
Direct
Shares
−500.00
Price / share
$75.70
Trade value
$37.85K
% of position
1.1%
10/1/2025
45.45K→44.95K
Total
Net shares
−2K
Net value
-$150.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2025 | S · Sale | −1.50K | $75.09 | $112.63K | 3.2% | 46.95K | 45.45K |
| Common Stock Direct | 10/1/2025 | S · Sale | −500.00 | $75.70 | $37.85K | 1.1% | 45.45K | 44.95K |
| Total | −2K | -$150.48K | ||||||
Derivative Transactions0
No derivative transactions reported